Australian Pharmaceutical Industries Ltd (API.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 08/31
| 08-2011 | 08-2010 | 08-2009 | 08-2008 | 04-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 34,605 | 29,431 | 5,856 | 42,906 | 21,315 |
| Receivables | 586,536 | 700,278 | 251,348 | 226,403 | 120,461 |
| Inventories | 320,154 | 322,148 | 292,902 | 269,058 | 256,492 |
| Income taxes - deferred | N/A | N/A | N/A | 3,326 | 14,068 |
| Other current assets | 0 | 0 | 0 | 0 | -412,336 |
| TOTAL | $941,295 | $1,051,857 | $550,106 | $541,693 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 119,929 | 128,285 | 112,307 | 85,236 | 76,046 |
| Investments And Advances | 27,815 | 24,304 | 23,667 | 24,668 | 26,330 |
| Intangibles | 194,761 | 197,092 | 200,073 | 202,462 | 217,524 |
| Other Non-Current Assets | 107,104 | 83,405 | 161,091 | 145,196 | -319,900 |
| TOTAL | $449,609 | $433,086 | $497,138 | $457,562 | $N/A |
| Total Assets | $1,390,904 | $1,484,943 | $1,047,244 | $999,255 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 184,271 | 200,187 | 8 | 9 | 6,764 |
| Accounts payable and accrued liabilities | 572,338 | 659,123 | 564,810 | 549,288 | 423,290 |
| TOTAL | $817,008 | $876,425 | $591,230 | $565,029 | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 4,885 | 4,931 | N/A |
| Other Non-Current Liabilities | 19,060 | 16,853 | 15,390 | 9,474 | -2,650 |
| TOTAL | $19,529 | $17,343 | $21,487 | $15,262 | $N/A |
| Total Liabilities | $836,537 | $893,768 | $612,717 | $580,291 | $N/A |
| Shareholders' Equity | |||||
| Common Shares | 566,461 | 566,461 | 419,499 | 419,499 | 419,499 |
| Retained earnings | -5,747 | 29,766 | 18,935 | 2,910 | -9,705 |
| Other shareholders' equity | -6,347 | -5,052 | -3,907 | -3,445 | 1,441 |
| TOTAL | $554,367 | $591,175 | $434,527 | $418,964 | $411,235 |
| Total Liabilities And Equity | $1,390,904 | $1,484,943 | $1,047,244 | $999,255 | $411,235 |